Mapping the Landscape of Anti–Breast Cancer Drug Discovery in Saudi Arabia: A Bibliometric Analysis (2019–2023)
Azizah M. Malebari, Abdulrahman A. Alghelis, Rashad S. Alzahrani, Anfal S. Aljahdali · 2025
Read Mapping the Landscape of Anti–Breast Cancer Drug Discovery in Saudi Arabia: A Bibliometric Analysis (2019–2023) by Azizah M. Malebari, Abdulrahman A. Alghelis, Rashad S. Alzahrani, Anfal S. Aljahdali (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12782350.txt.
Description
Azizah Malebari and co-authors map 2025 work on breast cancer drug research in Saudi Arabia over five years. Breast cancer is the most common cancer in the world and the top cancer in Saudi Arabia, with rates still rising. The country has poured more funds, tools, and training into drug research over the past two decades.
The team pulled 943 papers from a large science data bank for the years 2019 to 2023. Yearly output rose from under 100 papers to more than 250 in that span. Chemistry led the fields, then drug science, then the study of life chemicals. One university gave the most funds, and Saudi teams worked often with partners abroad. Hot terms were anti-cancer work, computer docking of drugs, and tiny drug carriers.
Catalog record
| CREATOR | Azizah M. Malebari, Abdulrahman A. Alghelis, Rashad S. Alzahrani, Anfal S. Aljahdali |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |